PDE4A and Alzheimer disease: Topical therapies for AD include topical corticosteroids (TCSs), calcineurin inhibitors (TCIs), and new topical treatments, such as topical phosphodiesterase 4 (PDE4) inhibitors, novel topical Janus kinase (JAK) inhibitors, tofacitinib and delgocitinib, and UV therapy.